257 related articles for article (PubMed ID: 14662868)
1. Anti-CD8 antibodies can inhibit or enhance peptide-MHC class I (pMHCI) multimer binding: this is paralleled by their effects on CTL activation and occurs in the absence of an interaction between pMHCI and CD8 on the cell surface.
Wooldridge L; Hutchinson SL; Choi EM; Lissina A; Jones E; Mirza F; Dunbar PR; Price DA; Cerundolo V; Sewell AK
J Immunol; 2003 Dec; 171(12):6650-60. PubMed ID: 14662868
[TBL] [Abstract][Full Text] [Related]
2. MHC class I molecules with Superenhanced CD8 binding properties bypass the requirement for cognate TCR recognition and nonspecifically activate CTLs.
Wooldridge L; Clement M; Lissina A; Edwards ES; Ladell K; Ekeruche J; Hewitt RE; Laugel B; Gostick E; Cole DK; Debets R; Berrevoets C; Miles JJ; Burrows SR; Price DA; Sewell AK
J Immunol; 2010 Apr; 184(7):3357-66. PubMed ID: 20190139
[TBL] [Abstract][Full Text] [Related]
3. Critical role for CD8 in binding of MHC tetramers to TCR: CD8 antibodies block specific binding of human tumor-specific MHC-peptide tetramers to TCR.
Denkberg G; Cohen CJ; Reiter Y
J Immunol; 2001 Jul; 167(1):270-6. PubMed ID: 11418659
[TBL] [Abstract][Full Text] [Related]
4. Anti-coreceptor antibodies profoundly affect staining with peptide-MHC class I and class II tetramers.
Wooldridge L; Scriba TJ; Milicic A; Laugel B; Gostick E; Price DA; Phillips RE; Sewell AK
Eur J Immunol; 2006 Jul; 36(7):1847-55. PubMed ID: 16783852
[TBL] [Abstract][Full Text] [Related]
5. Anti-CD8 antibodies can trigger CD8+ T cell effector function in the absence of TCR engagement and improve peptide-MHCI tetramer staining.
Clement M; Ladell K; Ekeruche-Makinde J; Miles JJ; Edwards ES; Dolton G; Williams T; Schauenburg AJ; Cole DK; Lauder SN; Gallimore AM; Godkin AJ; Burrows SR; Price DA; Sewell AK; Wooldridge L
J Immunol; 2011 Jul; 187(2):654-63. PubMed ID: 21677135
[TBL] [Abstract][Full Text] [Related]
6. High affinity xenoreactive TCR:MHC interaction recruits CD8 in absence of binding to MHC.
Buslepp J; Kerry SE; Loftus D; Frelinger JA; Appella E; Collins EJ
J Immunol; 2003 Jan; 170(1):373-83. PubMed ID: 12496422
[TBL] [Abstract][Full Text] [Related]
7. Different T cell receptor affinity thresholds and CD8 coreceptor dependence govern cytotoxic T lymphocyte activation and tetramer binding properties.
Laugel B; van den Berg HA; Gostick E; Cole DK; Wooldridge L; Boulter J; Milicic A; Price DA; Sewell AK
J Biol Chem; 2007 Aug; 282(33):23799-810. PubMed ID: 17540778
[TBL] [Abstract][Full Text] [Related]
8. Antibodies directed against the MHC-I molecule H-2Dd complexed with an antigenic peptide: similarities to a T cell receptor with the same specificity.
Polakova K; Plaksin D; Chung DH; Belyakov IM; Berzofsky JA; Margulies DH
J Immunol; 2000 Nov; 165(10):5703-12. PubMed ID: 11067928
[TBL] [Abstract][Full Text] [Related]
9. Glu227-->Lys substitution in the acidic loop of major histocompatibility complex class I alpha 3 domain distinguishes low avidity CD8 coreceptor and avidity-enhanced CD8 accessory functions.
Shen L; Potter TA; Kane KP
J Exp Med; 1996 Nov; 184(5):1671-83. PubMed ID: 8920857
[TBL] [Abstract][Full Text] [Related]
10. T cell receptor engagement of peptide-major histocompatibility complex class I does not modify CD8 binding.
Cole DK; Dunn SM; Sami M; Boulter JM; Jakobsen BK; Sewell AK
Mol Immunol; 2008 May; 45(9):2700-9. PubMed ID: 18243322
[TBL] [Abstract][Full Text] [Related]
11. Coreceptor CD8-driven modulation of T cell antigen receptor specificity.
van den Berg HA; Wooldridge L; Laugel B; Sewell AK
J Theor Biol; 2007 Nov; 249(2):395-408. PubMed ID: 17869274
[TBL] [Abstract][Full Text] [Related]
12. The human CD8 coreceptor effects cytotoxic T cell activation and antigen sensitivity primarily by mediating complete phosphorylation of the T cell receptor zeta chain.
Purbhoo MA; Boulter JM; Price DA; Vuidepot AL; Hourigan CS; Dunbar PR; Olson K; Dawson SJ; Phillips RE; Jakobsen BK; Bell JI; Sewell AK
J Biol Chem; 2001 Aug; 276(35):32786-92. PubMed ID: 11438524
[TBL] [Abstract][Full Text] [Related]
13. Enhanced immunogenicity of CTL antigens through mutation of the CD8 binding MHC class I invariant region.
Wooldridge L; Lissina A; Vernazza J; Gostick E; Laugel B; Hutchinson SL; Mirza F; Dunbar PR; Boulter JM; Glick M; Cerundolo V; van den Berg HA; Price DA; Sewell AK
Eur J Immunol; 2007 May; 37(5):1323-33. PubMed ID: 17429845
[TBL] [Abstract][Full Text] [Related]
14. High avidity antigen-specific CTL identified by CD8-independent tetramer staining.
Choi EM; Chen JL; Wooldridge L; Salio M; Lissina A; Lissin N; Hermans IF; Silk JD; Mirza F; Palmowski MJ; Dunbar PR; Jakobsen BK; Sewell AK; Cerundolo V
J Immunol; 2003 Nov; 171(10):5116-23. PubMed ID: 14607910
[TBL] [Abstract][Full Text] [Related]
15. Competitive inhibition in vivo and skewing of the T cell repertoire of antigen-specific CTL priming by an anti-peptide-MHC monoclonal antibody.
Chung DH; Belyakov IM; Derby MA; Wang J; Boyd LF; Berzofsky JA; Margulies DH
J Immunol; 2001 Jul; 167(2):699-707. PubMed ID: 11441073
[TBL] [Abstract][Full Text] [Related]
16. Species specificity in the interaction of CD8 with the alpha 3 domain of MHC class I molecules.
Newberg MH; Ridge JP; Vining DR; Salter RD; Engelhard VH
J Immunol; 1992 Jul; 149(1):136-42. PubMed ID: 1607650
[TBL] [Abstract][Full Text] [Related]
17. Archaeosomes induce long-term CD8+ cytotoxic T cell response to entrapped soluble protein by the exogenous cytosolic pathway, in the absence of CD4+ T cell help.
Krishnan L; Sad S; Patel GB; Sprott GD
J Immunol; 2000 Nov; 165(9):5177-85. PubMed ID: 11046050
[TBL] [Abstract][Full Text] [Related]
18. Characterization of anti-CD8-resistant cytolytic T lymphocytes induced by multivalent cross-linking of CD8 on precursor cells.
McCarthy SA; Kaldjian E; Singer A
J Immunol; 1989 Oct; 143(7):2112-9. PubMed ID: 2528588
[TBL] [Abstract][Full Text] [Related]
19. The duration of TCR/pMHC interactions regulates CTL effector function and tumor-killing capacity.
Riquelme E; Carreño LJ; González PA; Kalergis AM
Eur J Immunol; 2009 Aug; 39(8):2259-69. PubMed ID: 19637198
[TBL] [Abstract][Full Text] [Related]
20. The CD8 T cell coreceptor exhibits disproportionate biological activity at extremely low binding affinities.
Hutchinson SL; Wooldridge L; Tafuro S; Laugel B; Glick M; Boulter JM; Jakobsen BK; Price DA; Sewell AK
J Biol Chem; 2003 Jul; 278(27):24285-93. PubMed ID: 12697765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
